These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10891888)

  • 21. The role of tumor necrosis factor in health and disease.
    Beutler BA
    J Rheumatol Suppl; 1999 May; 57():16-21. PubMed ID: 10328138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG; Markomichelakis NN; Sfikakis PP
    Retina; 2007; 27(4):399-413. PubMed ID: 17420690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies.
    Tsimberidou AM; Giles FJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):277-86. PubMed ID: 12113051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Crohn's disease with anti-TNF alpha].
    Lémann M
    Rev Prat; 1998 May; 48(10):1049-50. PubMed ID: 9781146
    [No Abstract]   [Full Text] [Related]  

  • 25. New perspectives and emerging therapies for immune-mediated inflammatory disorders.
    Vizcarra C
    J Infus Nurs; 2003; 26(5):319-25. PubMed ID: 14506365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taming TNF: strategies to restrain this proinflammatory cytokine.
    Eigler A; Sinha B; Hartmann G; Endres S
    Immunol Today; 1997 Oct; 18(10):487-92. PubMed ID: 9357141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines.
    Greenberg P
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii41-2. PubMed ID: 11890651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-TNF Therapy.
    Udalova I; Monaco C; Nanchahal J; Feldmann M
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies?
    Tracey KJ; Abraham E
    Shock; 1999 Mar; 11(3):224-5. PubMed ID: 10188777
    [No Abstract]   [Full Text] [Related]  

  • 30. Biosimilars in Crohn's disease.
    Scheinberg M
    J Crohns Colitis; 2014 Jul; 8(7):710. PubMed ID: 24365641
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-cytokine therapies in response to systemic infection.
    Dinarello CA
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):244-50. PubMed ID: 11924836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-cytokine therapy: present status and future perspectives in nephrology].
    Panichi V; Paoletti S
    G Ital Nefrol; 2004; 21(5):446-53. PubMed ID: 15547876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triple anti-TNF-alpha therapy in early sepsis: a preliminary report.
    Schattner A; el-Hador I; Hahn T; Landau Z
    J Int Med Res; 1997; 25(2):112-6. PubMed ID: 9100167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonists of TNF action: clinical experience and new developments.
    Kontermann RE; Scheurich P; Pfizenmaier K
    Expert Opin Drug Discov; 2009 Mar; 4(3):279-92. PubMed ID: 23489126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Suppression of synthesis of tumor necrosis factor].
    Eigler A; Loher F; Endres S
    Internist (Berl); 2001 Jan; 42(1):28-34. PubMed ID: 11271618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials referral resource. Myelodysplastic syndromes.
    Cheson BD; Arbuck SG; Phillips PH
    Oncology (Williston Park); 1995 Sep; 9(9):821-2, 825. PubMed ID: 8562324
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions.
    Sloan SR; Andrzejewski C; Aqui NA; Kiss JE; Krause PJ; Park YA
    J Clin Apher; 2015 Oct; 30(5):259-64. PubMed ID: 25351167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crohn's disease and the myelodysplastic syndrome.
    Castellote J; Porta F; Tuset E; Salinas R
    J Clin Gastroenterol; 1997 Jun; 24(4):286-7. PubMed ID: 9252862
    [No Abstract]   [Full Text] [Related]  

  • 39. Disease-modifying treatment of chemical threat agent-induced acute lung injury.
    Radbel J; Laskin DL; Laskin JD; Kipen HM
    Ann N Y Acad Sci; 2020 Nov; 1480(1):14-29. PubMed ID: 32726497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved Disease Modules Extracted From Multilayer Heterogeneous Disease and Gene Networks for Understanding Disease Mechanisms and Predicting Disease Treatments.
    Yu L; Yao S; Gao L; Zha Y
    Front Genet; 2018; 9():745. PubMed ID: 30713550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.